Related references
Note: Only part of the references are listed.Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
Matthias Pinter et al.
GUT (2021)
Hepatocellular carcinoma in non-alcoholic fatty liver disease-a review of an emerging challenge facing clinicians
Daniel Geh et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Report of the 20th Nationwide follow-up survey of primary liver cancer in Japan
Masatoshi Kudo et al.
HEPATOLOGY RESEARCH (2020)
PD-1 gene rs10204525 and rs7421861 polymorphisms are associated with increased risk and clinical features of esophageal cancer in a Chinese Han population
Bao Zang et al.
AGING-US (2020)
Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease
Stefano Romeo et al.
CELL METABOLISM (2020)
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Stephen A. Harrison et al.
JOURNAL OF HEPATOLOGY (2020)
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort
Quentin M. Anstee et al.
JOURNAL OF HEPATOLOGY (2020)
A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification
Cristiana Bianco et al.
JOURNAL OF HEPATOLOGY (2020)
CD44, IL-33, and ST2 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility in the Chinese Population
Xiaolan Pan et al.
BIOMED RESEARCH INTERNATIONAL (2020)
EASL recommendations on treatment of hepatitis C: Final update of the series
Jean-Michel Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2020)
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Timothy Hardy et al.
CONTEMPORARY CLINICAL TRIALS (2020)
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms
Rasha El Sharkawy et al.
SCIENTIFIC REPORTS (2019)
The Natural History of Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: Data From the Simtuzumab Trials
Arun J. Sanyal et al.
HEPATOLOGY (2019)
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Association of rs10204525 genotype GG and rs2227982 CC combination in programmed cell death 1 with hepatitis B virus infection risk
Chunhong Huang et al.
MEDICINE (2019)
Association between PD-1 and PD-L1 Polymorphisms and the Risk of Cancer: A Meta-Analysis of Case-Control Studies
Mohammad Hashemi et al.
CANCERS (2019)
Association of TM6SF2 rs58542926 T/C gene polymorphism with hepatocellular carcinoma: a meta-analysis
Shan Tang et al.
BMC CANCER (2019)
Association of PD-1 polymorphisms with the risk and prognosis of lung adenocarcinoma in the northeastern Chinese Han population
Kun Huang et al.
BMC MEDICAL GENETICS (2019)
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Serena Pelusi et al.
SCIENTIFIC REPORTS (2019)
PD-1 and cancer: molecular mechanisms and polymorphisms
Arash Salmaninejad et al.
IMMUNOGENETICS (2018)
Annotation-free quantification of RNA splicing using LeafCutter
Yang I. Li et al.
NATURE GENETICS (2018)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Programmed cell death-1 3-untranslated region polymorphism is associated with spontaneous clearance of hepatitis B virus infection
Hajar Chihab et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
Trends and Disparities in Cardiovascular Mortality Among US Adults With and Without Self-Reported Diabetes, 1988-2015
Yiling J. Cheng et al.
DIABETES CARE (2018)
The Genetics of Clinical Liver Diseases: Insight into the TM6SF2 E167K Variant
Xiaoyu Zhang et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)
Quantifying the regulatory effect size of cis-acting genetic variation using allelic fold change
Pejman Mohammadi et al.
GENOME RESEARCH (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases
Amal A. Mohamed et al.
JOURNAL OF ADVANCED RESEARCH (2017)
PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis
Edmondo Falleti et al.
DIGESTIVE AND LIVER DISEASE (2016)
Genetic and Epigenetic Regulation of PD-1 Expression
Alexander P. R. Bally et al.
JOURNAL OF IMMUNOLOGY (2016)
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway
Vassiliki A. Boussiotis
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies
Wenjing Dong et al.
PLOS ONE (2016)
Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption
Kate Frazer et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
HUMAN GENETICS GTEx pilot quantifies eQTL variation across tissues and individuals
Orli G. Bahcall
NATURE REVIEWS GENETICS (2015)
The Genotype-Tissue Expression (GTEx) Project
Latarsha J. Carithers et al.
BIOPRESERVATION AND BIOBANKING (2015)
NAFLD leads to liver cancer: Do we have sufficient evidence?
Xiao-Yan Duan et al.
CANCER LETTERS (2014)
The Transcription Factor FoxO1 Sustains Expression of the Inhibitory Receptor PD-1 and Survival of Antiviral CD8+ T Cells during Chronic Infection
Matthew M. Staron et al.
IMMUNITY (2014)
PD-1 mRNA expression is associated with clinical and viral profile and PD1 3′-untranslated region polymorphism in patients with chronic HBV infection
Guoyu Zhang et al.
IMMUNOLOGY LETTERS (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
Y. -L. Liu et al.
JOURNAL OF HEPATOLOGY (2014)
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Yang-Lin Liu et al.
NATURE COMMUNICATIONS (2014)
CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
Ying-Erh Chou et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Genetic variations of PD1 and TIM3 are differentially and interactively associated with the development of cirrhosis and HCC in patients with chronic HBV infection
Zhu Li et al.
INFECTION GENETICS AND EVOLUTION (2013)
Transcriptome and genome sequencing uncovers functional variation in humans
Tuuli Lappalainen et al.
NATURE (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma
Vinod Kumar et al.
NATURE GENETICS (2011)
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Brad Q. Starley et al.
HEPATOLOGY (2010)
Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Jason Z. Liu et al.
NATURE GENETICS (2010)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data
Frank Dudbridge
HUMAN HEREDITY (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A new paradigm for drug discovery: integrating clinical, genetic, genomic and molecular phenotype data to identify drug targets
EE Schadt et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival
K Endo et al.
JOURNAL OF HEPATOLOGY (2000)
Share Paper
